Navigation Links
Surefire Infusion System Found Safe and Effective for Delivery of 90Y in Treating Inoperable Liver Cancer
Date:7/10/2013

WESTMINSTER, Colo., July 10, 2013 /PRNewswire/ -- Case reports published in the Journal of Cardiovascular and Interventional Radiology found that by using the Surefire Infusion System, radioembolization could be successfully performed without the need to protect nearby blood vessels, a significant advance that may enable doctors to safely extend liver cancer treatment to patients who were previously deemed untreatable.

None of the three patients, including one who otherwise could not have been treated, suffered complications as a result of the minimally invasive procedure.  All were discharged the following day.

"With the protection from reflux afforded by Surefire's novel, expandable, funnel-shaped tip we performed successful yttrium-90 radioembolization without coiling," said Prof. Dr. Maurice van den Bosch, Interventional Radiologist, University Medical Center Utrecht, The Netherlands.  "Positron emission tomography-computed tomography (PET-CT) confirmed adequate, efficient biodistribution of the microspheres in targeted liver segments only."

In recent years, Interventional Oncology has emerged as a pillar of modern cancer care.  In numerous clinical studies, improved patient outcomes have been achieved with embolization therapy and systemic chemotherapy compared to systemic chemotherapy alone.

"We are gratified that our advanced technology enables a broader population of patients to be treated, including those who otherwise may not have received treatment," said Surefire Medical CEO Jim Chomas.  "These case studies add to the rapidly growing body of clinical evidence indicating that the Surefire Infusion System safely, efficiently and precisely delivers therapy.  It may contribute not only to enhanced treatment effectiveness, but also to the palliation of cancers to improve quality of life."

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop a new class of infusion systems for the interventional radiology and interventional oncology markets.  Surefire's infusion systems are designed to precisely deliver embolic agents through a unique microcatheter with an expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow in order to maximize targeted delivery, minimize reflux and reduce damage to healthy tissue.  For more information, please visit www.surefiremedical.com.


'/>"/>
SOURCE Surefire Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
2. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
3. Christopher Mennone Joins Surefire Medical Team As International Business Director
4. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
5. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
6. Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study
7. Sirtex To Distribute Surefire Medicals Innovative Infusion System in Australia and Asia Pacific Markets
8. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
9. CareFusion Expands Infusion Pump Interoperability
10. Global Infusion Pumps Market 2011-2015
11. Riordan Lewis & Haden
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
(Date:5/24/2016)... May 24, 2016 Open Access ... Clinical Neurophysiology  Elsevier , a world-leading ... services, today announced the launch of Clinical ... journal that focuses on clinical practice issues in clinical ... clinical series, normal values and didactic reviews. It is ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... An April Gallup survey found rising ... 550 employees of Sun Health Senior Living (SHSL) may not share those ... doctor and prescription copays for the year, while holding the line on increasing their ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Lung Institute ... a six-week smoking cessation class starting June 6 at their clinic in downtown Tampa. ... . , Additionally, the Lung Institute has created a free downloadable 4 Week ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... Top Doc! Along with his wonderful accolades and stellar patient reviews, Dr. Batelli ... Dr. Batelli! , Dr. Eugene Batelli is a highly trained Podiatric Surgeon who ...
(Date:5/26/2016)... ... May 26, 2016 , ... A health conscious snack that doesn't ... Bar, has ignited an undeniable buzz in the protein product community by offering ... any doughnut.  These doughnuts are packed with 11 grams of protein and made from ...
(Date:5/26/2016)... York, NY (PRWEB) , ... May 26, 2016 , ... ... have lips been so central to popular cosmetic improvement efforts. Record numbers of clients ... kissers appear more prominent or pouty, says Kally Papantoniou, MD, of Advanced Dermatology ...
Breaking Medicine News(10 mins):